Clinical characteristics of ulcerative colitis in elderly patients

被引：5
作者：
Zhu, Mingming [1 ]
Ran, Zhihua [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol,Shanghai Inst Digest, Key Lab Gastroenterol & Hepatol,Renji Hosp,Sch Me, Minist Hlth,Shanghai Inflammatory Bowel Dis Res C, Shanghai 200127, Peoples R China
来源：
JGH OPEN | 2021年 / 5卷 / 08期
关键词：
clinical characteristics; elderly; medical therapy; ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; ANTI-TNF THERAPY; NATURAL-HISTORY; OPPORTUNISTIC INFECTIONS; SERIOUS INFECTIONS; COLORECTAL-CANCER; RISK-FACTORS; ONSET; SAFETY; VEDOLIZUMAB;
D O I：
10.1002/jgh3.12612
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The incidence of ulcerative colitis (UC) in elderly patients is increasing. Elderly UC patients are likely to exhibit distinct features both at diagnosis and during follow-up. Age-related problems, including complications, immune dysfunction, and multidrug use, make the diagnosis and treatment of elderly UC more challenging. Suboptimal treatment considering adverse events leads to poor clinical outcome in elderly UC patients. Here, we reviewed the epidemiology, clinical presentation, medical therapy, colorectal cancer surveillance of UC in elderly patients.
引用
收藏
页码：849 / 854
页数：6
相关论文
共 71 条
  • [11] Safety of Thiopurine Therapy in Inflammatory Bowel Disease: Long-term Follow-up Study of 3931 Patients
    Chaparro, Maria
    Ordas, Ingrid
    Cabre, Eduard
    Garcia-Sanchez, Valle
    Bastida, Guillermo
    Penalva, Mireia
    Gomollon, Fernando
    Garcia-Planella, Esther
    Merino, Olga
    Gutierrez, Ana
    Esteve, Maria
    Marquez, Lucia
    Garcia-Sepulcre, Maria
    Hinojosa, Joaquin
    Vera, Isabel
    Munoz, Fernando
    Mendoza, Juan L.
    Cabriada, Jose L.
    Montoro, Miguel A.
    Barreiro-de Acosta, Manuel
    Cena, G.
    Saro, Cristina
    Aldeguer, Xavier
    Barrio, Jesus
    Mate, Jose
    Gisbert, Javier P.
    [J]. INFLAMMATORY BOWEL DISEASES, 2013, 19 (07) : 1404 - 1410
  • [12] Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study
    Charpentier, Cloe
    Salleron, Julia
    Savoye, Guillaume
    Fumery, Mathurin
    Merle, Veronique
    Laberenne, Jean-Eric
    Vasseur, Francis
    Dupas, Jean-Louis
    Cortot, Antoine
    Dauchet, Luc
    Peyrin-Biroulet, Laurent
    Lerebours, Eric
    Colombel, Jean-Frederic
    Gower-Rousseau, Corinne
    [J]. GUT, 2014, 63 (03) : 423 - 432
  • [13] Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study
    Cheddani, Halima
    Dauchet, Luc
    Fumery, Mathurin
    Charpentier, Cloe
    Bouvier, Anne Marie
    Dupas, Jean-Louis
    Pariente, Benjamin
    Peyrin-Biroulet, Laurent
    Savoye, Guillaume
    Gower-Rousseau, Corinne
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (10) : 1428 - 1436
  • [14] Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials
    Cheng, David
    Cushing, Kelly C.
    Cai, Tianxi
    Ananthakrishnan, Ashwin N.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (05) : 939 - +
  • [15] ClinicalTrials.gov, 2017, SAF STUDY TOF VERS T
  • [16] Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease
    Cottone, Mario
    Kohn, Anna
    Daperno, Marco
    Armuzzi, Alessandro
    Guidi, Luisa
    D'Inca, Renata
    Bossa, Fabrizio
    Angelucci, Erika
    Biancone, Livia
    Gionchetti, Paolo
    Ardizzone, Sandro
    Papi, Claudio
    Fries, Walter
    Danese, Silvio
    Riegler, Gabriele
    Cappello, Maria
    Castiglione, Fabiana
    Annese, Vito
    Orlando, Ambrogio
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (01) : 30 - 35
  • [17] Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis
    Cross, Raymond K.
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 (10) : 1689 - 1701
  • [18] Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience
    D'Amico, Ferdinando
    Parigi, Tommaso Lorenzo
    Fiorino, Gionata
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [19] Older Age Is Associated with Higher Rate of Discontinuation of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease
    Desai, Amit
    Zator, Zachary A.
    de Silva, Punyanganie
    Nguyen, Deanna D.
    Korzenik, Joshua
    Yajnik, Vijay
    Ananthakrishnan, Ashwin N.
    [J]. INFLAMMATORY BOWEL DISEASES, 2013, 19 (02) : 309 - 315
  • [20] The risk of colorectal cancer in ulcerative colitis: a meta-analysis
    Eaden, JA
    Abrams, KR
    Mayberry, JF
    [J]. GUT, 2001, 48 (04) : 526 - 535
12345678